Wang Xiankun, Lin Ling, Zhao Zhenghua, Zhou Wei, Ge Zirou, Shen Yi, Wang Lin, Zhang Wei, Song Rui, Tian Di, Wen Jing, Cui Shuping, Yu Xiaoli, Feng Yang, Liu Yuanni, Qiang Chunqian, Duan Jianping, Ma Yanli, Li Xingwang, Fan Tianli, Zhao Yongxiang, Chen Zhihai
Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University. Beijing, China.
Department of Infectious Diseases, Yantai City Hospital for Infectious Disease, Yantai, China.
Ann Transl Med. 2021 Feb;9(3):208. doi: 10.21037/atm-20-4736.
Severe fever with thrombocytopenia syndrome is caused by infection with the severe fever with thrombocytopenia syndrome virus.
Between April 2011 and December 2019, data on consecutive patients who were diagnosed with severe fever with thrombocytopenia syndrome were prospectively collected from five medical centers in China. The score of the death risk model was correlated with the platelet-to-lymphocyte ratio and the neutrophil-to-lymphocyte ratio. Multivariable Cox analyses were used to identify the independent factors associated with mortality.
During the study period, 763 patients were diagnosed with severe fever with thrombocytopenia syndrome; 415 of these patients were enrolled in our study. We found that the neutrophil-to-lymphocyte ratio of the group that died was significantly higher on admission (P=0.007) than that of the group that survived, and the neutrophil-to-lymphocyte ratio showed a positive correlation with the score of the death risk model. Multivariate Cox regression suggested that a neutrophil-to-lymphocyte ratio greater than 5.4 was an independent risk factor for survival time (HR=6.767, P=0.011). Platelet-to-lymphocyte ratio did not show a special role in this study.
A neutrophil-to-lymphocyte ratio greater than 5.4 can increase the risk of death and decrease the survival time of patients. In summary, the neutrophil-to-lymphocyte ratio provides a supplementary means for effectively managing severe fever with thrombocytopenia syndrome (SFTS).
发热伴血小板减少综合征由发热伴血小板减少综合征病毒感染引起。
2011年4月至2019年12月期间,前瞻性收集了来自中国五个医疗中心连续诊断为发热伴血小板减少综合征患者的数据。死亡风险模型评分与血小板与淋巴细胞比值及中性粒细胞与淋巴细胞比值相关。采用多变量Cox分析确定与死亡率相关的独立因素。
研究期间,763例患者被诊断为发热伴血小板减少综合征;其中415例患者纳入本研究。我们发现,死亡组入院时的中性粒细胞与淋巴细胞比值显著高于存活组(P=0.007),且中性粒细胞与淋巴细胞比值与死亡风险模型评分呈正相关。多变量Cox回归表明,中性粒细胞与淋巴细胞比值大于5.4是生存时间的独立危险因素(HR=6.767,P=0.011)。血小板与淋巴细胞比值在本研究中未显示出特殊作用。
中性粒细胞与淋巴细胞比值大于5.4可增加患者死亡风险并缩短生存时间。总之,中性粒细胞与淋巴细胞比值为有效管理发热伴血小板减少综合征(SFTS)提供了一种补充手段。